Zibotentan, an endothelin A receptor antagonist, prevents Aβ-induced hypertension and maintains cerebral perfusion: ERA prevents Aβ-induced hypertension
暂无分享,去创建一个
[1] C. Tzourio,et al. Antihypertensive medications and risk for incident dementia and Alzheimer's disease: a meta-analysis of individual participant data from prospective cohort studies , 2019, The Lancet Neurology.
[2] J. Whitwell,et al. Alzheimer's disease neuroimaging , 2018, Current opinion in neurology.
[3] M. Kivimäki,et al. Association between systolic blood pressure and dementia in the Whitehall II cohort study: role of age, duration, and threshold used to define hypertension , 2018, European heart journal.
[4] P. Kehoe. The Coming of Age of the Angiotensin Hypothesis in Alzheimer’s Disease: Progress Toward Disease Prevention and Treatment? , 2018, Journal of Alzheimer's disease : JAD.
[5] L. Sheng,et al. Aberrant pattern of regional cerebral blood flow in Alzheimer's disease: a voxel-wise meta-analysis of arterial spin labeling MR imaging studies , 2017, Oncotarget.
[6] D. Nation,et al. Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia , 2017, Brain : a journal of neurology.
[7] P. Kehoe,et al. Angiotensin-III is Increased in Alzheimer's Disease in Association with Amyloid-β and Tau Pathology. , 2017, Journal of Alzheimer's disease : JAD.
[8] M. Iglarz,et al. Endothelin ETA Receptor Blockade, by Activating ETB Receptors, Increases Vascular Permeability and Induces Exaggerated Fluid Retention , 2017, The Journal of Pharmacology and Experimental Therapeutics.
[9] S. Love,et al. Differing associations between Aβ accumulation, hypoperfusion, blood–brain barrier dysfunction and loss of PDGFRB pericyte marker in the precuneus and parietal white matter in Alzheimer's disease , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[10] Ashley D Harris,et al. Is High Blood Pressure Self-Protection for the Brain? , 2016, Circulation research.
[11] S. Love,et al. Cerebral Hypoperfusion and the Energy Deficit in Alzheimer's Disease , 2016, Brain pathology.
[12] Frederik Barkhof,et al. Lower cerebral blood flow is associated with faster cognitive decline in Alzheimer’s disease , 2016, European Radiology.
[13] Nick C Fox,et al. White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer network , 2016, Annals of neurology.
[14] Seth Love,et al. Pathophysiology of Hypoperfusion of the Precuneus in Early Alzheimer's Disease , 2015, Brain pathology.
[15] R. Speich,et al. Disease-Targeted Treatment Improves Cognitive Function in Patients with Precapillary Pulmonary Hypertension , 2015, Respiration.
[16] M. Iglarz,et al. Vascular Effects of Endothelin Receptor Antagonists Depends on Their Selectivity for ETA Versus ETB Receptors and on the Functionality of Endothelial ETB Receptors , 2015, Journal of cardiovascular pharmacology.
[17] S. Briyal,et al. Stimulation of endothelin B receptors by IRL-1620 decreases the progression of Alzheimer’s disease , 2015, Neuroscience.
[18] Seth Love,et al. Post-mortem assessment of hypoperfusion of cerebral cortex in Alzheimer's disease and vascular dementia. , 2015, Brain : a journal of neurology.
[19] Nirmal Singh,et al. Efficacy of bosentan, a dual ETA and ETB endothelin receptor antagonist, in experimental diabetes induced vascular endothelial dysfunction and associated dementia in rats , 2014, Pharmacology Biochemistry and Behavior.
[20] Ping Zhou,et al. Age-Dependent Neurovascular Dysfunction and Damage in a Mouse Model of Cerebral Amyloid Angiopathy , 2014, Stroke.
[21] Benjamin D. Levine,et al. Global brain hypoperfusion and oxygenation in amnestic mild cognitive impairment , 2014, Alzheimer's & Dementia.
[22] B. Zlokovic,et al. Pericyte loss influences Alzheimer-like neurodegeneration in mice , 2013, Nature Communications.
[23] J. Pernow,et al. New perspectives on endothelin-1 in atherosclerosis and diabetes mellitus. , 2012, Life sciences.
[24] Jesse D. Sengillo,et al. Blood–spinal cord barrier pericyte reductions contribute to increased capillary permeability , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[25] Nathan T. Ross,et al. A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease. , 2012, The Journal of clinical investigation.
[26] Rong Zhang,et al. Oscillations in cerebral blood flow and cortical oxygenation in Alzheimer's disease , 2012, Neurobiology of Aging.
[27] B. Zlokovic,et al. Central nervous system pericytes in health and disease , 2011, Nature Neuroscience.
[28] S. Love,et al. Endothelin receptor antagonists: potential in Alzheimer's disease. , 2011, Pharmacological research.
[29] Berislav V. Zlokovic,et al. Pericytes Control Key Neurovascular Functions and Neuronal Phenotype in the Adult Brain and during Brain Aging , 2010, Neuron.
[30] S. Love,et al. Endothelin‐converting enzyme‐1 in Alzheimer's disease and vascular dementia , 2010, Neuropathology and applied neurobiology.
[31] C. Kilkenny,et al. Guidelines for reporting experiments involving animals: the ARRIVE guidelines , 2010, British journal of pharmacology.
[32] Yaakov Stern,et al. Multivariate and Univariate Analysis of Continuous Arterial Spin Labeling Perfusion MRI in Alzheimer's Disease , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[33] Ping Zhou,et al. Nox2-derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor protein , 2008, Proceedings of the National Academy of Sciences.
[34] D. Rotella,et al. Very low-frequency blood pressure variability depends on voltage-gated L-type Ca2+ channels in conscious rats. , 2007, American journal of physiology. Heart and circulatory physiology.
[35] D. Webb,et al. Specific inhibition of the endothelin A receptor with ZD4054: clinical and pre-clinical evidence , 2005, British Journal of Cancer.
[36] J. Paton,et al. Dynamic Exercise Attenuates Spontaneous Baroreceptor Reflex Sensitivity in Conscious Rats , 2003, Experimental physiology.
[37] Ann Marie Schmidt,et al. RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain , 2003, Nature Medicine.
[38] George A. Carlson,et al. Exogenous Aβ1–40 Reproduces Cerebrovascular Alterations Resulting from Amyloid Precursor Protein Overexpression in Mice , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[39] C. Iadecola,et al. Abeta 1-40-related reduction in functional hyperemia in mouse neocortex during somatosensory activation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[40] J. Detre,et al. Assessment of cerebral blood flow in Alzheimer's disease by spin‐labeled magnetic resonance imaging , 2000, Annals of neurology.
[41] D. Borchelt,et al. SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein , 1999, Nature Neuroscience.
[42] C. Iadecola,et al. Increased Susceptibility to Ischemic Brain Damage in Transgenic Mice Overexpressing the Amyloid Precursor Protein , 1997, The Journal of Neuroscience.
[43] S. Oparil,et al. Enhanced endothelin-1 and endothelin receptor gene expression in chronic hypoxia. , 1994, Journal of applied physiology.
[44] T. Goldberg,et al. Cerebral blood flow measured by arterial spin labeling MRI at resting state in normal aging and Alzheimer’s disease , 2017, Neuroscience & Biobehavioral Reviews.
[45] Joep Lagro,et al. Impaired cerebral autoregulation and vasomotor reactivity in sporadic Alzheimer's disease. , 2014, Current Alzheimer research.
[46] Christina E. Wierenga,et al. Cerebral blood flow measured by arterial spin labeling MRI as a preclinical marker of Alzheimer's disease. , 2014, Journal of Alzheimer's disease : JAD.
[47] D. Salmon,et al. Cortical and subcortical cerebrovascular resistance index in mild cognitive impairment and Alzheimer's disease. , 2013, Journal of Alzheimer's disease : JAD.
[48] S. Love,et al. Endothelin-converting enzyme-1 activity, endothelin-1 production, and free radical-dependent vasoconstriction in Alzheimer's disease. , 2013, Journal of Alzheimer's disease : JAD.
[49] S. Love,et al. Endothelin-1 is elevated in Alzheimer's disease and upregulated by amyloid-β. , 2012, Journal of Alzheimer's disease : JAD.
[50] S. Love,et al. ACE variants and association with brain Aβ levels in Alzheimer's disease. , 2010, American journal of translational research.
[51] M. Mullan,et al. beta-Amyloid-mediated vasoactivity and vascular endothelial damage. , 1996, Nature.